l carnitine hypertension The therapeutic prospects of using l-carnitine to manage hypertension-related organ damage Ameliorating Hypertension and Insulin Resistance
Description
BACH1 is increased in cystic fibrosis and chronic obstructive pulmonary disease (COPD) patients and is linked to respiratory impairment
In February of 2007, development of AOD 9604 was halted when there was no weight loss found in a 24-week clinical trial
Conventional treatment options for PD include medications, surgery, and lifestyle changes
These antibodies can indicate an autoimmune process long before other lab changes become apparent
